Distinct APCs explain the cytokine bias of α-galactosylceramide variants in vivo. - Wikidata - wikimedia - TriplyDB

Distinct APCs explain the cytokine bias of α-galactosylceramide variants in vivo.

Distinct APCs explain the cytokine bias of α-galactosylceramide variants in vivo.

http://www.wikidata.org/entity/Q35850748

about

CD1d- and MR1-Restricted T Cells in Sepsis Turned on by danger: activation of CD1d-restricted invariant natural killer T cells Enhanced TCR Footprint by a Novel Glycolipid Increases NKT-Dependent Tumor Protection Intravital imaging - dynamic insights into natural killer T cell biology An in silico approach for modelling T-helper polarizing iNKT cell agonists Raising the roof: the preferential pharmacological stimulation of Th1 and th2 responses mediated by NKT cells.Natural killer T (NKT) cells in autoimmune hepatitis Reciprocal Crosstalk between Dendritic Cells and Natural Killer T Cells: Mechanisms and Therapeutic Potential.Critical role of NKT cells in posttransplant alloantibody production.Cd1d regulates B cell development but not B cell accumulation and IL10 production in mice with pathologic CD5(+) B cell expansion A Subset of CD8αβ+ Invariant NKT Cells in a Humanized Mouse Model Short term high fat diet challenge promotes alternative macrophage polarization in adipose tissue via natural killer T cells and interleukin-4.Endocytic pH regulates cell surface localization of glycolipid antigen loaded CD1d complexes Connecting the dots: artificial antigen presenting cell-mediated modulation of natural killer T cells.Targeted delivery of lipid antigen to macrophages via the CD169/sialoadhesin endocytic pathway induces robust invariant natural killer T cell activation Recognition of CD1d-restricted antigens by natural killer T cells.Natural killer T (NKT)-B-cell interactions promote prolonged antibody responses and long-term memory to pneumococcal capsular polysaccharides.Effective functional maturation of invariant natural killer T cells is constrained by negative selection and T-cell antigen receptor affinity.A single subset of dendritic cells controls the cytokine bias of natural killer T cell responses to diverse glycolipid antigens B cells in T follicular helper cell development and function: separable roles in delivery of ICOS ligand and antigen Molecular basis of lipid antigen presentation by CD1d and recognition by natural killer T cells.Invariant natural killer T cells in adipose tissue: novel regulators of immune-mediated metabolic disease.Genetic dissection of dendritic cell homeostasis and function: lessons from cell type-specific gene ablation Enhancing dendritic cell-based vaccination for highly aggressive glioblastoma.Natural Killer T cell subsets in eutopic and ectopic endometrium: a fresh look to a busy corner.Lactic acid in tumor microenvironments causes dysfunction of NKT cells by interfering with mTOR signaling.Glycolipid activators of invariant NKT cells as vaccine adjuvants.Activation strategies for invariant natural killer T cells.iNKT cell cytotoxic responses control T-lymphoma growth in vitro and in vivo .CD1d-mediated activation of group 3 innate lymphoid cells drives IL-22 production.Cytotoxic lymphocytes and atherosclerosis: significance, mechanisms and therapeutic challenges.Selective Conditions Are Required for the Induction of Invariant NKT Cell Hyporesponsiveness by Antigenic Stimulation.A Novel Glycolipid Antigen for NKT Cells That Preferentially Induces IFN-γ Production.Communication between natural killer T cells and adipocytes in obesity.Adipocyte-specific CD1d-deficiency mitigates diet-induced obesity and insulin resistance in mice.Natural Killer T Cells: An Ecological Evolutionary Developmental Biology Perspective.M2-specific reduction of CD1d switches NKT cell-mediated immune responses and triggers metaflammation in adipose tissue.Induction of antiinflammatory purinergic signaling in activated human iNKT cells Mrp1 is involved in lipid presentation and iNKT cell activation by Streptococcus pneumoniae Peripheral Dopamine Controlled by Gut Microbes Inhibits Invariant Natural Killer T Cell-Mediated Hepatitis

P2860

Q26796132-55698E19-DB91-4094-8169-DD98CF7573B1 Q26825059-0E5072E9-5FEC-4736-825D-E3B07C116CFA Q27679771-81A54D74-FFDD-4192-AAF8-5C8903EE9957 Q28081530-EF545555-9096-4D37-9292-2916FF4D0DA1 Q28539366-93FF7C52-069B-43C2-959B-B3B8255888DE Q30408873-77D43FBF-C1B1-4273-B714-61736D968C7C Q33580295-913E1B5D-7992-40A5-8604-71E985149E15 Q33720359-8BB90F19-7A8F-4355-B3CD-B8C996235B34 Q34392504-0AB2020F-BE12-4074-8E49-6C66F47C68FD Q35832809-14AFA08B-8023-490D-86F4-04032DDBBEA9 Q35931493-30E196A4-5D09-4920-A5AB-6F38BE5D04B6 Q36097975-B1852E5B-CA27-46E2-B2F1-330D3C59C60E Q36249071-8CD48F45-C156-475B-BFC4-B165CD10B37D Q36383130-424E62C9-21BA-4384-AE15-5F9B6B2B6D73 Q36835483-E2DF3C2B-9CEE-4EDA-B82B-6494EA99C6AB Q37088000-79BED633-83D9-44B1-B05F-2070562B15E4 Q37218293-4CBC738E-DDF2-4244-9564-9250101A767A Q37474745-B7CB5776-FAC7-4B59-8DB1-EAB43C9B7DD1 Q37491277-7F79636C-910D-4F96-A9E0-36E88814AA4F Q37710145-2F707809-397D-431B-9CAE-886CD97FEF73 Q38050484-A1376E97-D819-47C3-8E2F-B3CC511A84D9 Q38120169-AE2AE488-A2FB-4C3C-BB29-8C5E9EE10468 Q38173662-2B0A7CB9-3142-425F-AE85-5DE8CEFDA7AA Q38261273-97107179-884A-464B-A6A6-D3B32E00FFAC Q38688814-15A4C8F7-3C4E-44FB-8E5C-A591A023320F Q38725344-2B279CA5-77FC-4971-B56D-1D4F165570C2 Q38885794-F68EE2EE-053F-4820-BE34-1C09D2AEE5E4 Q38908501-575B9582-8067-4B6B-B029-8734FB054036 Q39021436-03C59244-7AE9-42C7-A930-14C10598FD4F Q39230029-DB3087B4-1FF6-4CDE-A76B-E651332A82E5 Q39283173-3434628C-B4E3-4241-A5F6-0A76B5A9EDA4 Q40556221-0EFCDFCC-8339-4E9E-B0BD-3AADC5F21683 Q40832140-C6629482-65B5-4324-83A7-4EA6AF16F440 Q41813424-71CAF4A9-1A40-4DFD-9B8A-939DC86D126B Q41865522-0DF65F7C-D84F-4AA7-A4B9-717685E2ECD3 Q47221129-D92BAE20-73A7-4761-9AC6-DB34B3F0F34B Q53507353-D7DFD10C-90B4-428A-91BC-9B951AAA4220 Q57444218-F181EC5D-9027-4EA0-B0FC-ADE08E0C53CB Q57464724-76A5A798-5BF9-4DD0-9050-4F4B50614873 Q58606329-B48703B7-9567-48BE-9FF2-ECFEFD6568D0

P2860

Distinct APCs explain the cytokine bias of α-galactosylceramide variants in vivo.

http://www.wikidata.org/entity/Q35850748

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Distinct APCs explain the cytokine bias of α-galactosylceramide variants in vivo.

@ast

Distinct APCs explain the cytokine bias of α-galactosylceramide variants in vivo.

@en

type

label

Distinct APCs explain the cytokine bias of α-galactosylceramide variants in vivo.

@ast

Distinct APCs explain the cytokine bias of α-galactosylceramide variants in vivo.

@en

prefLabel

Distinct APCs explain the cytokine bias of α-galactosylceramide variants in vivo.

@ast

Distinct APCs explain the cytokine bias of α-galactosylceramide variants in vivo.

@en

P1433

Q35850748-D23DD02E-24C8-48E3-8C34-A0B05A407E84

P1476

Q35850748-DFD4877F-9591-455A-814B-BE931011693F

P2093

Q35850748-0FA799DE-01F1-47AD-863B-69BC74CE3665

Q35850748-6AC8125C-D234-4CD8-BB6B-F32B0E331C4A

Q35850748-7AD5C91A-D696-4EC9-A835-A29C560E870B

Q35850748-9EEF0D19-B15D-4A27-8A9E-24704201887F

Q35850748-D85A4C0A-5540-446D-8BB2-BB16936FD6FF

Q35850748-E279C635-2619-483E-952D-619E8BD3BF67

Q35850748-E3585BBF-2F9D-44B6-86AA-22F4186EC8EA

P2860

Q35850748-061F98EC-4E33-48BD-910E-C559AA26C491

Q35850748-0BAAE7A2-E06B-454A-8750-0565CCFA7065

Q35850748-0FC7E1B9-0CBF-4C77-88E8-CF3E8ACF9AE3

Q35850748-11A81500-1969-438F-893B-9822992EB301

Q35850748-1265BF88-74AF-4E11-88D3-D068A5B148F0

Q35850748-3402FC14-3AB9-45C5-9631-897E7DC5C1B3

Q35850748-3690836B-5583-42A1-A958-9ECFF1879C78

Q35850748-3A4B4E1C-74E1-474B-9298-8DF2D810F45A

Q35850748-3EF41BDE-AE25-422C-AE8F-EE7901BE0B57

Q35850748-3F57585F-78F7-402C-8CD4-DD9BDAF30047

P304

Q35850748-807C85B7-B8B0-4901-BD41-33C4B39A75BA

P31

Q35850748-BFBE9292-2E55-47BA-8D8D-1EB9D3101187

P356

Q35850748-BBA8BCF4-9D90-4B25-96C2-66FFC54A00F9

P407

Q35850748-CDF7531C-8CBF-476A-8EC1-0AC2C8B6114F

P433

Q35850748-4508006E-0FCC-4D2B-93BF-93B2F0F61982

P478

Q35850748-C32B7AA2-890A-476B-AFE9-B7FA310C7809

P50

Q35850748-04802969-A153-4A91-9C36-19949C7C3485

Q35850748-D88CABDC-C69F-49C9-A769-DD0DE67619CA

P577

Q35850748-6ECF9F28-CECC-4C46-A89C-399F9C291192

P5875

Q35850748-DDA8C1E6-0B3A-440F-BF46-BEE0650052F6

P698

Q35850748-F3F770C3-416E-4C7E-BF28-715394DCD5CA

P921

Q35850748-D2D3EDB5-C655-4891-8BA5-DE9041F00C0B

P932

Q35850748-8764A9DB-CB34-47CD-BE70-480E071E5CED

P356

JIMMUNOL.1102414

P1433

Journal of Immunology

P1476

Distinct APCs explain the cytokine bias of α-galactosylceramide variants in vivo

@en

P2093

Albert Bendelac

http://www.w3.org/2001/XMLSchema#string

Fanyong Meng

http://www.w3.org/2001/XMLSchema#string

Frank Koentgen

http://www.w3.org/2001/XMLSchema#string

Li Bai

http://www.w3.org/2001/XMLSchema#string

Luc Teyton

http://www.w3.org/2001/XMLSchema#string

Paul B Savage

http://www.w3.org/2001/XMLSchema#string

Rachel Reboulet

http://www.w3.org/2001/XMLSchema#string

P2860

The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions

The transcription factor PLZF directs the effector program of the NKT cell lineage

Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor

Mechanisms for Glycolipid Antigen-Driven Cytokine Polarization by V 14i NKT Cells

A Molecular Basis for the Exquisite CD1d-Restricted Antigen Specificity and Functional Responses of Natural Killer T Cells

Apolipoprotein-mediated pathways of lipid antigen presentation

The biology of NKT cells

Homotypic interactions mediated by Slamf1 and Slamf6 receptors control NKT cell lineage development

CD1d endosomal trafficking is independently regulated by an intrinsic CD1d-encoded tyrosine motif and by the invariant chain

PD-1/PD-L blockade prevents anergy induction and enhances the anti-tumor activities of glycolipid-activated invariant NKT cells

P304

3053-3061

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.1102414

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

188

http://www.w3.org/2001/XMLSchema#string

P50

Michael G Constantinides

P577

2012-03-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221890719

http://www.w3.org/2001/XMLSchema#string

P698

22393151

http://www.w3.org/2001/XMLSchema#string

P921

P932

3311697

http://www.w3.org/2001/XMLSchema#string